Advertisement
Screener

TETRAPHASE PHARMACEUTICALS INC Operating Income

TETRAPHASE PHARMACEUTICALS INC Operating Income

TETRAPHASE PHARMACEUTICALS INC reported Operating Income of -$12.26 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2020-05-07

  • TETRAPHASE PHARMACEUTICALS INC operating income (loss) for the quarter ending 2020-03-31 was -$12.26M.
  • TETRAPHASE PHARMACEUTICALS INC operating income (loss) for the quarter ending 2019-12-31 was -$11.54M.
  • TETRAPHASE PHARMACEUTICALS INC operating income (loss) for the quarter ending 2019-09-30 was -$14.34M.
  • TETRAPHASE PHARMACEUTICALS INC operating income (loss) for the quarter ending 2019-06-30 was -$22.61M.
  • TETRAPHASE PHARMACEUTICALS INC operating income (loss) for fiscal 2019 was -$67.53M.
  • TETRAPHASE PHARMACEUTICALS INC operating income (loss) for fiscal 2018 was -$73.28M.
  • TETRAPHASE PHARMACEUTICALS INC operating income (loss) for fiscal 2017 was -$115.72M.
  • TETRAPHASE PHARMACEUTICALS INC operating income (loss) for fiscal 2016 was -$77.83M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 monthOperating Income (Loss) 81 monthOperating Income (Loss) 84 monthOperating Income (Loss) 87 monthOperating Income (Loss) 90 monthOperating Income (Loss) 93 month
2020-03-31-$12.26M
10-Q · filed 2020-05-07
-$23.81M
derived: sum of 2 quarters · filed 2020-05-07
-$38.14M
derived: sum of 3 quarters · filed 2020-05-07
-$60.76M
derived: sum of 4 quarters · filed 2020-05-07
2019-12-31-$11.54M
10-K · filed 2020-03-12
-$25.88M
derived: sum of 2 quarters · filed 2020-03-12
-$48.49M
derived: sum of 3 quarters · filed 2020-03-12
-$67.53M
10-K · filed 2020-03-12
2019-09-30-$14.34M
10-K · filed 2020-03-12
-$36.95M
derived: sum of 2 quarters · filed 2020-03-12
-$55.99M
10-Q · filed 2019-11-12
-$77.38M
derived: sum of 4 quarters · filed 2020-05-07
2019-06-30-$22.61M
10-K · filed 2020-03-12
-$41.65M
10-Q · filed 2019-08-08
-$63.04M
derived: sum of 3 quarters · filed 2020-05-07
-$83.04M
derived: sum of 4 quarters · filed 2020-05-07
2019-03-31-$19.04M
10-Q · filed 2020-05-07
-$40.43M
derived: sum of 2 quarters · filed 2020-05-07
-$60.42M
derived: sum of 3 quarters · filed 2020-05-07
-$70.38M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31-$21.39M
10-K · filed 2020-03-12
-$41.38M
derived: sum of 2 quarters · filed 2020-03-12
-$51.34M
derived: sum of 3 quarters · filed 2020-03-12
-$73.28M
10-K · filed 2020-03-12
2018-09-30-$20.00M
10-K · filed 2020-03-12
-$29.95M
derived: sum of 2 quarters · filed 2020-03-12
-$51.89M
10-Q · filed 2019-11-12
-$75.71M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$9.96M
10-K · filed 2020-03-12
-$31.90M
10-Q · filed 2019-08-08
-$55.72M
derived: sum of 3 quarters · filed 2020-03-12
-$86.03M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31-$21.94M
10-K · filed 2020-03-12
-$45.76M
derived: sum of 2 quarters · filed 2020-03-12
-$76.07M
derived: sum of 3 quarters · filed 2020-03-12
-$108.06M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31-$23.82M
10-K · filed 2019-03-15
-$54.13M
derived: sum of 2 quarters · filed 2019-03-15
-$86.12M
derived: sum of 3 quarters · filed 2019-03-15
-$115.72M
10-K · filed 2019-03-15
2017-09-30-$30.31M
10-K · filed 2019-03-15
-$62.30M
derived: sum of 2 quarters · filed 2019-03-15
-$91.90M
10-Q · filed 2018-11-09
-$114.45M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30-$31.99M
10-K · filed 2019-03-15
-$61.59M
10-Q · filed 2018-08-02
-$84.14M
derived: sum of 3 quarters · filed 2019-03-15
-$105.34M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31-$29.59M
10-K · filed 2019-03-15
-$52.15M
derived: sum of 2 quarters · filed 2019-03-15
-$73.35M
derived: sum of 3 quarters · filed 2019-03-15
-$90.61M
derived: sum of 4 quarters · filed 2019-03-15
2016-12-31-$22.56M
10-K · filed 2018-03-06
-$43.75M
derived: sum of 2 quarters · filed 2018-03-06
-$61.02M
derived: sum of 3 quarters · filed 2018-03-06
-$77.83M
10-K · filed 2018-03-06
2016-09-30-$21.20M
10-K · filed 2018-03-06
-$38.46M
derived: sum of 2 quarters · filed 2018-03-06
-$55.27M
10-Q · filed 2017-11-01
-$73.41M
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30-$17.26M
10-K · filed 2018-03-06
-$34.08M
10-Q · filed 2017-08-02
-$52.21M
derived: sum of 3 quarters · filed 2018-03-06
-$70.26M
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31-$16.81M
10-K · filed 2018-03-06
-$34.95M
derived: sum of 2 quarters · filed 2018-03-06
-$53.00M
derived: sum of 3 quarters · filed 2018-03-06
-$79.05M
derived: sum of 4 quarters · filed 2018-03-06
2015-12-31-$18.13M
10-K · filed 2017-03-13
-$36.19M
derived: sum of 2 quarters · filed 2017-03-13
-$62.24M
derived: sum of 3 quarters · filed 2017-03-13
-$83.00M
10-K · filed 2018-03-06
2015-09-30-$18.05M
10-K · filed 2017-03-13
-$44.11M
derived: sum of 2 quarters · filed 2017-03-13
-$64.87M
10-Q · filed 2016-11-03
-$85.25M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30-$26.05M
10-K · filed 2017-03-13
-$46.81M
10-Q · filed 2016-08-04
-$67.20M
derived: sum of 3 quarters · filed 2017-03-13
-$81.18M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31-$20.76M
10-K · filed 2017-03-13
-$41.14M
derived: sum of 2 quarters · filed 2017-03-13
-$55.12M
derived: sum of 3 quarters · filed 2017-03-13
-$73.31M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31-$20.38M
10-K · filed 2016-02-25
-$34.36M
derived: sum of 2 quarters · filed 2016-02-25
-$52.55M
derived: sum of 3 quarters · filed 2016-02-25
-$65.77M
10-K · filed 2017-03-13
2014-09-30-$13.98M
10-K · filed 2016-02-25
-$32.16M
derived: sum of 2 quarters · filed 2016-02-25
-$45.38M
10-Q · filed 2015-11-02
-$56.31M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30-$18.18M
10-K · filed 2016-02-25
-$31.40M
10-Q · filed 2015-08-06
-$42.33M
derived: sum of 3 quarters · filed 2016-02-25
-$52.01M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31-$13.22M
10-K · filed 2016-02-25
-$24.14M
derived: sum of 2 quarters · filed 2016-02-25
-$33.83M
derived: sum of 3 quarters · filed 2016-02-25
-$38.78M
derived: sum of 4 quarters · filed 2016-02-25
-$126.03M
10-Q · filed 2014-05-12
2013-12-31-$10.92M
10-K · filed 2015-03-06
-$20.61M
derived: sum of 2 quarters · filed 2015-03-06
-$25.57M
derived: sum of 3 quarters · filed 2015-03-06
-$28.19M
10-K · filed 2016-02-25
-$112.81M
10-K · filed 2014-03-06
2013-09-30-$9.69M
10-K · filed 2015-03-06
-$14.64M
derived: sum of 2 quarters · filed 2015-03-06
-$17.27M
10-Q · filed 2014-11-10
-$19.97M
derived: sum of 4 quarters · filed 2015-03-06
-$101.89M
10-Q · filed 2013-11-14
2013-06-30-$4.96M
10-K · filed 2015-03-06
-$7.58M
10-Q · filed 2014-08-12
-$10.28M
derived: sum of 3 quarters · filed 2015-03-06
-$13.18M
derived: sum of 4 quarters · filed 2015-03-06
-$92.21M
10-Q · filed 2013-08-12
2013-03-31-$2.62M
10-K · filed 2015-03-06
-$5.33M
derived: sum of 2 quarters · filed 2015-03-06
-$8.22M
derived: sum of 3 quarters · filed 2015-03-06
-$12.17M
derived: sum of 4 quarters · filed 2015-03-06
-$87.25M
10-Q · filed 2013-05-13
2012-12-31-$2.70M
10-K · filed 2014-03-06
-$5.60M
derived: sum of 2 quarters · filed 2014-03-06
-$9.55M
derived: sum of 3 quarters · filed 2014-03-06
-$14.00M
10-K · filed 2015-03-06
2012-09-30-$2.90M
10-K · filed 2014-03-06
-$6.85M
derived: sum of 2 quarters · filed 2014-03-06
-$11.30M
10-Q · filed 2013-11-14
2012-06-30-$3.95M
10-K · filed 2014-03-06
-$8.40M
10-Q · filed 2013-08-12
2012-03-31-$4.46M
10-K · filed 2014-03-06
2011-12-31-$21.43M
10-K · filed 2014-03-06